Literature DB >> 31021991

Low Rate of Sex-specific Analyses in Presentations at the Conference on Retroviruses and Opportunistic Infections (CROI) Meeting, 2018: Room to Improve.

Monica Gandhi1, Laura M Smeaton2, Christina Vernon3, Eileen P Scully4, Sara Gianella5, Selvamuthu Poongulali6, Anandi N Sheth7, Marije Van Schalkwyk8, Karin L Klingman9, William R Short10, Valarie S Opollo11, Susan E Cohn12, Kimberly K Scarsi13, Cindy Firnhaber14, Sara Bares15, Shobha Swaminathan16, Rosie Mngqibisa17, Elizabeth Connick18.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31021991      PMCID： PMC6625875          DOI： 10.1097/QAI.0000000000002073

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  14 in total

1.  A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without Emtricitabine.

Authors:  Mackenzie L Cottrell; Kuo H Yang; Heather M A Prince; Craig Sykes; Nicole White; Stephanie Malone; Evan S Dellon; Ryan D Madanick; Nicholas J Shaheen; Michael G Hudgens; Jacob Wulff; Kristine B Patterson; Julie A E Nelson; Angela D M Kashuba
Journal:  J Infect Dis       Date:  2016-02-24       Impact factor: 5.226

2.  Reporting Sex, Gender, or Both in Clinical Research?

Authors:  Janine Austin Clayton; Cara Tannenbaum
Journal:  JAMA       Date:  2016-11-08       Impact factor: 56.272

Review 3.  Sex differences in immune responses.

Authors:  Sabra L Klein; Katie L Flanagan
Journal:  Nat Rev Immunol       Date:  2016-08-22       Impact factor: 53.106

4.  Applying the new SABV (sex as a biological variable) policy to research and clinical care.

Authors:  Janine Austin Clayton
Journal:  Physiol Behav       Date:  2017-08-17

5.  Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission.

Authors:  Kristine B Patterson; Heather A Prince; Eric Kraft; Amanda J Jenkins; Nicholas J Shaheen; James F Rooney; Myron S Cohen; Angela D M Kashuba
Journal:  Sci Transl Med       Date:  2011-12-07       Impact factor: 17.956

6.  Promoting the understanding of sex differences to enhance equity and excellence in biomedical science.

Authors:  Arthur P Arnold
Journal:  Biol Sex Differ       Date:  2010-11-04       Impact factor: 5.027

7.  Is there gender bias in HIV cure research? A case study of female representation at the 2015 HIV Persistence Workshop.

Authors:  Rowena Johnston; Suteeraporn Pinyakorn; Jintanat Ananworanich
Journal:  J Virus Erad       Date:  2016-04-01

8.  Women's involvement in clinical trials: historical perspective and future implications.

Authors:  Katherine A Liu; Natalie A Dipietro Mager
Journal:  Pharm Pract (Granada)       Date:  2016-03-15

9.  Women in HIV cure research: multilevel interventions to improve sex equity in recruitment.

Authors:  Mary E Grewe; Yuntong Ma; Adam Gilbertson; Stuart Rennie; Joseph D Tucker
Journal:  J Virus Erad       Date:  2016

Review 10.  Sex as an important biological variable in biomedical research.

Authors:  Suk Kyeong Lee
Journal:  BMB Rep       Date:  2018-04       Impact factor: 4.778
View more
  4 in total

1.  Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum.

Authors:  Laura M Smeaton; Emma M Kileel; Beatriz Grinsztejn; Edward M Gardner; Kate Starr; Melissa L Murry; Patrice Desvigne-Nickens; Beverly Alston-Smith; Myron A Waclawiw; Katharine Cooper-Arnold; José V Madruga; Shashi Sangle; Kathleen V Fitch; Markella V Zanni; Pamela S Douglas; Heather J Ribaudo; Steven K Grinspoon; Karin L Klingman
Journal:  J Infect Dis       Date:  2020-07-09       Impact factor: 5.226

2.  Sex differences in type 2 diabetes mellitus prevalence among persons with HIV.

Authors:  Morgan Birabaharan; Andrew Strunk; David C Kaelber; Davey M Smith; Thomas C S Martin
Journal:  AIDS       Date:  2022-03-01       Impact factor: 4.177

3.  Incident Non-AIDS Comorbidity Burden Among Women With or at Risk for Human Immunodeficiency Virus in the United States.

Authors:  Lauren F Collins; Anandi N Sheth; C Christina Mehta; Susanna Naggie; Elizabeth T Golub; Kathryn Anastos; Audrey L French; Seble Kassaye; Tonya N Taylor; Margaret A Fischl; Adaora A Adimora; Mirjam-Colette Kempf; Frank J Palella; Phyllis C Tien; Ighovwerha Ofotokun
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 9.079

4.  The Prevalence and Burden of Non-AIDS Comorbidities Among Women Living With or at Risk for Human Immunodeficiency Virus Infection in the United States.

Authors:  Lauren F Collins; Anandi N Sheth; C Christina Mehta; Susanna Naggie; Elizabeth T Golub; Kathryn Anastos; Audrey L French; Seble Kassaye; Tonya Taylor; Margaret A Fischl; Adaora A Adimora; Mirjam-Colette Kempf; Frank J Palella; Phyllis C Tien; Ighovwerha Ofotokun
Journal:  Clin Infect Dis       Date:  2021-04-26       Impact factor: 20.999
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.